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A B S T R A C T  
Emphysematous urinary tract infections (UTIs) are infections of the lower or upper urinary tract associated with gas 
formation. They may manifest as cystitis, pyelitis, or pyelonephritis. Diabetes mellitus is a major risk factor for these 
infections. The diagnosis of gas-forming UTI is usually made by plain films of the abdomen and/or computed tomography 
(CT). Escherichia coli and Klebsiella pneumonia are the predominant etiologic organisms. We present a rare case of 
emphysematous cystitis along with emphysematous pyelonephritis in a patient with poorly controlled diabetes. This 
patient underwent nephrectomy and 500 ml of puss was drained before nephrectomy. Puss C/S showed growth of 
Escherichia coli which was sensitive to pipercillin/tazobactam. We conclude that all female diabetic patients more than 
60 years of age presenting with urinary symptoms, abdominal pain, fever and evidence of UTI on urine routine 
examination should have at-least an ultrasound abdomen and kidney ureter bladder (KUB) done and if presence of air is 
suspected, these patients should get CT scan KUB done so that diagnosis of emphysematous UTI be made and 
managed accordingly. 
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I n t r o d u c t i o n  
 
Emphysematous urinary tract infections (UTIs) are 
infections of the lower or upper urinary tract associated 
with gas formation. They may manifest as cystitis, pyelitis, 
or pyelonephritis. Diabetes mellitus is a major risk factor 
for these infections and is also associated with an 
increased risk of asymptomatic bacteriuria and certain 
symptomatic UTIs such as cystitis, renal and perinephric 
abscess, and Candida infections.1-3 Elevated tissue 
glucose levels in diabetic patients may provide a more 
favorable microenvironment for gas-forming microbes. 
However, bacterial gas production does not fully explain 
the pathologic and clinical manifestations of 
emphysematous UTIs.4,5 Diabetes mellitus and urinary 
tract obstruction are the major risk factors for 
emphysematous urinary tract infections (UTIs). In different 
series, diabetes was present in more than 80 percent of 
patients with emphysematous pyelonephritis.4,6 The 
diagnosis of a gas-forming UTI is usually made by plain 
films of the abdomen and/or computed tomography (CT). 
Such radiographs reveal air in the renal parenchyma, 
bladder, or surrounding tissue in 50 to 85 percent of 
cases. CT scanning is more sensitive than plain films and 
may show the extent of gas formation and any obstructing 
lesions in the urinary tract.4,5,7 Escherichia 
coli and Klebsiella pneumoniae are the predominant 
etiologic organisms.8 Treatment modalities include 
intravenous (I/V) antibiotics, percutaneous drainage 
(PCD) and nephrectomy. 
C a s e  R e p o r t  
A 64-year-old female was admitted to intensive care unit 
(ICU) via outpatient department (OPD) with complaint of 
CASE REPORT 
                            226 JIMDC   2018  226 
fever, abdominal pain, vomiting and burning micturition. 
Her fever was acute in onset, high grade, intermittent for 
last 2 days. Her abdominal pain was described as ―achy,‖ 
6/10, intermittent, and located in the right upper quadrant 
without radiation. She also had complaint of vomiting, 4 
episodes in last 2 days, not containing blood and burning 
micturition along with mild dysuria. She was diagnosed 
Diabetes Mellitus (DM) 1 year back during a routine 
checkup and was started on oral hypoglycemics (OHGs). 
Her blood sugar control was not adequate so 6 months 
later, she was started on Humulin 70/30 (NPH 
70%/Regular insulin 30%) with no regular follow ups. 
Apart from DM she had no other comorbid condition. She 
denied ever having any surgeries. She used regular 
insulin, omeprazole and diclofenac in past. Her family 
history was noncontributory, and she denied tobacco use. 
examination revealed a temperature of 100.6° F, 
respiratory rate of 16 breaths per minute, heart rate of 96 
beats per minute, blood pressure of 110/60 mm Hg, 
oxygen saturation of 98% at room air, and no edema was 
appreciated. Her fasting capillary blood glucose was 385 
mg/dL. She was oriented in time, person and place with a 
Glasgow coma scale (GCS) score of 15/15. Her pupils 
were equally reactive to light and accommodation. Rest of 
the neurological examination was unremarkable. The 
cardiac exam was normal with audible 1st and 2nd heart 
sound respiratory examination revealed bilateral breath 
sounds with reduced breath sounds and vocal resonance 
at right base, trachea was central. The abdomen was soft 
with moderate tenderness to palpation in the right 
hypochondrium and lumbar region. There was no 
guarding or rebound tenderness. 
Laboratory tests revealed the following: white blood cell 
(WBC) count, 9,100/mm3 with 85% Neutrophils; 
Hemoglobin, 13.1 g/dL; Platelet count, 61,000/mm3; Urea, 
161 mg/dL; Serum Creatinine, 3.3 mg/dL; Sodium, 130 
mmol/L; Potassium, 3.8 mmol/L; Alanine transaminase, 
10 IU/L; Prothrombin time, 15.4/10.6 seconds (INR 1.4); 
activated partial thromboplastin time, 37.2/29 seconds; 
Serum Calcium, 9 mg/dL; Serum Phosphorus, 2.8 mg/dL; 
Serum Bicarbonate, 15.7 mmol/L; Anti-HCV antibodies 
was Positive. The urinalysis revealed Protein 1+, red 
blood cells 10/HPF, and WBC numerous/HPF. Urine 
Culture/ Sensitivity (C/S) was negative for any growth. 
Ultrasound abdomen revealed enlarged hydronephrotic 
right kidney with few calculi at lower pole and few air 
loculi. Irregular liver margins, right sided pleural effusion 
and mild ascites. Non-contrast computed tomography 
(CT) scan of the abdomen was ordered. The CT scan 
revealed significant air in the bladder wall, consistent with 
Emphysematous Cystitis along with air in the right renal 
parenchyma extending to perinephric area consistent with 
Emphysematous Pyelonephritis. There were few calculi 
found at the lower pole as well. A diagnosis of 
Emphysematous Cystitis along with Class 3A 
Emphysematous Pyelonephritis was made. 
She was managed with intravenous (I/V) antibiotics 
including Pipercillin/Tazobactam 2.25 gm 8 hourly initially, 
dose adjusted according to estimated GFR and later as 
the renal functions improved, full 4.5 gm 8 hourly dose 
was administered, moxifloxacin 400 mg once a day and 
metronidazole 500 mg 8 hourly. I/V normal saline was 
started. Insulin regular was given according to sliding 
scale. Ranitidine was given for ulcer prophylaxis and 
tramadol was given for pain. After CT report, urology 
consult was taken and unanimous decision of right 
nephrectomy was made. Patient underwent nephrectomy 
under general anesthesia via right lumbar incision. 500 ml 
of puss was drained before nephrectomy. Puss C/S 
showed growth of Escherichia coli which was sensitive to 
Pipercillin/Tazobactam. Patient was again started on I/V 
antibiotics with a plan to discharge patient on oral 
antibiotics. 
 
Figure 1: (a) Computed tomography (CT) image 
showing air level extending to right perinephric area. 
(b) showing air level involving right renal 
parenchyma. (c) CT image showing hydroaeric level 
and pneumobladder at the level of bladder wall. 
D i s c u s s i o n  
Emphysematous pyelonephritis (EPN) was first described 
in 1898, in association with pneumaturia as a result of gas 
forming pathogens.9 These bacteria ferment sugars within 
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the urine producing gases including nitrogen, hydrogen, 
carbon dioxide, and oxygen.10 EPN occurs nearly 
exclusively (90%) in people with diabetes.11 The factors 
that predispose to EPN in people with diabetes may 
include uncontrolled diabetes, high levels of glycosylated 
hemoglobin, and impaired host immune mechanisms 
caused by local factors such as renal tract obstruction 
(tumours or lithiasis).12 Renal USS can confirm the 
presence of EPN in approximately 80% of cases13, 
whereas CT is 100% sensitive.14  Based upon the findings 
seen on CT scan, two classification systems have been 
proposed to estimate prognosis and guide therapy. One 
classification system divided emphysematous 
pyelonephritis into two types:15 
 Type I — Renal parenchymal necrosis with either 
absence of fluid collection or the presence of a 
streaky or mottled gas pattern 
 Type II — Renal or perirenal fluid accompanied by a 
bubbly gas pattern or gas in the collecting system 
Emphysematous pyelonephritis or pyelitis may be 
alternatively categorized into four prognostic classes 
based upon CT scan findings:11 
 Class 1: Gas in the collecting system only (ie, 
emphysematous pyelitis); this finding may be 
associated with severe obstruction at the site of the 
pyelitis in some patients 
 Class 2: Gas in the renal parenchyma without 
extension to the extrarenal space 
 Class 3A: Extension of gas or abscess to the 
perinephric space (defined as the area between the 
fibrous renal capsule and the renal fascia) 
 Class 3B: Extension of gas or abscess to the 
pararenal space (defined as the space beyond the 
renal fascia and/or extension to adjacent tissues such 
as the psoas muscle) 
 Class 4: Bilateral emphysematous pyelonephritis or a 
solitary functioning kidney with emphysematous 
pyelonephritis. 
Treatment of these patients has always been tough and 
controversial as limited data has been published. Patients 
with class 1 disease (pyelitis) who do not have abscess 
formation or obstruction can be treated with antibiotics 
alone.16 Other patients with class 1 disease and patients 
with class 2 disease should be treated with antibiotics 
plus percutaneous catheter drainage (PCD) and, if 
present, relief of urinary tract obstruction.17 Patients with 
class 3A or 3B disease at low risk (defined as none or one 
of the following risk factors: thrombocytopenia, acute 
renal failure, impaired consciousness, or shock) can 
initially be treated with antibiotics plus PCD and, if 
present, relief of urinary tract obstruction. However, given 
the lack of confirmatory evidence beyond the one study11, 
some urologists feel that early nephrectomy is warranted 
in all patients with class 3 disease. Patients with class 3A 
or 3B disease with two or more of the above risk factors 
should be treated with antibiotics plus immediate 
nephrectomy. Patients with class 4 disease (bilateral 
involvement or infection is a solitary functioning kidney) 
should initially be treated with antibiotics plus bilateral 
percutaneous catheter drainage and, if present, relief of 
urinary tract obstruction. Nephrectomy is a last option. 
Emphysematous cystitis is a lower urinary tract infection 
characterized by air within the bladder wall and lumen, 
usually occurring in elderly diabetic females, 
immunocompromised patients.18 Multiple gas-forming 
microorganisms can cause emphysematous cystitis. It 
was reported that various bacterial and fungal organisms 
were isolated in urine culture with Escherichia coli being 
the most prevalent, followed by Klebsiella pneumonia.18,19 
The treatment generally consists of antibiotics, bladder 
drainage, and glycemic control with correction of any 
underlying comorbid disorders. Broad-spectrum 
antibiotics are used initially. The precise regimen is then 
tapered to the sensitivities of the urinary pathogens.18  
When treated with antibiotics alone, EPN is associated 
with a high mortality rate (40%).20 Mortality rates were 15–
20% in two case series in which nephrectomy was the 
treatment of choice.21 In case of Emphysematous cystitis, 
the overall mortality rate was 7%, which increased to 14% 
in patients who presented with combined emphysematous 
cystitis and pyelonephritis.22 
C o n c l u s i o n  
Female diabetic patients more than 60 years of age 
presenting with urinary symptoms, abdominal pain, fever 
and evidence of UTI on urine routine examination should 
have at-least an ultrasound abdomen and kidney ureter 
bladder (KUB) done and if presence of air is suspected, 
these patients should get CT scan KUB so that diagnosis 
of emphysematous UTI can be made early as the 
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treatment depends upon proper diagnosis. Nephrectomy 
in Class 3A EPN along with emphysematous cystitis is the 
treatment of choice. 
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